From GlobeNewswire: 2025-05-28 08:00:00

Mesa Laboratories, a global leader in life science tools, reported a 5.5% increase in revenues for the fourth quarter of fiscal year 2025 compared to the same period in 2024. Operating income rose by 100.5% to $1,469, while non-GAAP core organic revenues growth was 6.3%. Full fiscal year revenues increased by 11.5% to $240,978, with operating income up 106.0% to $16,336.

The company operates in four divisions: Sterilization and Disinfection Control (SDC), Clinical Genomics (CG), Biopharmaceutical Development (BPD), and Calibration Solutions (CS). Mesa Laboratories saw growth in all four divisions in the fourth quarter of FY25, with strong momentum in SDC. Profitability was impacted by increased performance-based compensation expenses.

Mesa Laboratories achieved several strategic milestones in FY25, including successful acquisitions, product launches, and process improvements. The company also saw increased traction with its Commercial Excellence initiatives and the implementation of Salesforce CRM across all divisions. The Mesa Way, focusing on operational resilience and adaptability, drove success in various process improvement events.

For the fiscal year ending in March 2025, Mesa Laboratories reduced inventories by 22.4% and generated $46,808 in cash flows from operations. The company’s focus on driving profitable market share growth remains strong, despite global economic uncertainties and tariff escalations. Mesa’s revenue base is resilient, with a high mix of recurring services and consumables.

In the fourth quarter of FY25, Mesa Laboratories reported total revenues of $62,135, a 5.5% increase compared to the same period in 2024. Operating income increased by 100.5% to $1,469, with a net loss of $(7,114). Non-GAAP core organic revenues growth was 6.3%, and adjusted operating income decreased by 18.0% excluding unusual items.

For the full fiscal year 2025, Mesa Laboratories reported total revenues of $240,978, an 11.5% increase compared to FY24. Operating income increased by 106.0% to $16,336, with a net loss of $(1,974). Non-GAAP core organic revenues growth was 5.0%, and adjusted operating income increased by 12.3% excluding unusual items.



Read more at GlobeNewswire:: Mesa Labs Announces Fourth Quarter and Full Fiscal Year